MANNKIND CORP Gain (Loss) Related to Litigation Settlement
MANNKIND CORP (MNKD) reported Gain (Loss) Related to Litigation Settlement of -$6.49 million for the 271-month period ending 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2013-11-12
- 2013-09-30: Gain (Loss) Related to Litigation Settlement 271 month -$6.49M.
- 2013-06-30: Gain (Loss) Related to Litigation Settlement 268 month -$6.49M.
- 2013-03-31: Gain (Loss) Related to Litigation Settlement 265 month -$6.49M.
| Period end | Gain (Loss) Related to Litigation Settlement 265 month | Gain (Loss) Related to Litigation Settlement 268 month | Gain (Loss) Related to Litigation Settlement 271 month |
|---|---|---|---|
| 2013-09-30 | -$6.49M 10-Q · filed 2013-11-12 | ||
| 2013-06-30 | -$6.49M 10-Q · filed 2013-08-09 | ||
| 2013-03-31 | -$6.49M 10-Q · filed 2013-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |